Biotechnology
The Biotechnology industry has a total of 611 stocks, with a combined market cap of $1.06 trillion and total revenue of $105.45 billion.
Market Cap
1.06T
Revenue
105.45B
Profits
-42.77B
PE Ratio
n/a
Profit Margin
-40.56%
Dividend Yield
0.04%
611 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 107.15B | 0.31% | 1,188,723 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 75.62B | 5.01% | 2,286,978 | 14.25B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 58.90B | -3.25% | 787,524 | 3.21B |
| 4 | ARGX | argenx SE | 56.71B | 0.43% | 271,582 | 3.68B |
| 5 | INSM | Insmed Incorporated | 42.58B | -1.93% | 2,332,972 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 38.65B | -1.27% | 210,180 | 5.00B |
| 7 | BNTX | BioNTech SE | 23.32B | -4.40% | 1,179,934 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 22.16B | -0.67% | 2,678,479 | 2.35B |
| 9 | INCY | Incyte Corporation | 19.98B | 0.43% | 1,672,550 | 4.81B |
| 10 | GMAB | Genmab A/S | 18.61B | -1.73% | 1,154,568 | 3.85B |
| 11 | ROIV | Roivant Sciences Ltd. | 14.10B | -0.34% | 8,913,028 | 20.33M |
| 12 | RVMD | Revolution Medicines, Inc. | 13.51B | -0.92% | 2,350,930 | - |
| 13 | ASND | Ascendis Pharma A/S | 12.81B | -1.18% | 333,995 | 758.59M |
| 14 | SMMT | Summit Therapeutics Inc. | 12.69B | -0.66% | 2,695,346 | - |
| 15 | BBIO | BridgeBio Pharma, Inc. | 12.45B | -1.40% | 2,062,383 | 353.78M |
| 16 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.31B | -2.43% | 270,657 | 740.64M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 11.84B | -1.19% | 3,158,716 | 966.96M |
| 18 | EXEL | Exelixis, Inc. | 11.25B | -0.85% | 2,297,330 | 2.29B |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 10.68B | -0.19% | 1,676,557 | 4.16B |
| 20 | RNA | Avidity Biosciences, Inc. | 10.65B | -0.34% | 2,921,822 | 20.87M |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.08B | -0.15% | 2,127,994 | 3.09B |
| 22 | ABVX | ABIVAX Société Anonyme | 9.40B | 8.81% | 4,465,885 | 7.07M |
| 23 | TECH | Bio-Techne Corporation | 9.15B | 1.59% | 1,533,953 | 1.22B |
| 24 | MRNA | Moderna, Inc. | 8.74B | -7.53% | 18,612,611 | 2.23B |
| 25 | HALO | Halozyme Therapeutics, Inc. | 8.11B | -1.82% | 1,017,991 | 1.24B |
| 26 | CORT | Corcept Therapeutics Incorporated | 7.89B | -1.38% | 733,368 | 741.17M |
| 27 | NUVL | Nuvalent, Inc. | 7.85B | 0.82% | 1,000,022 | - |
| 28 | CYTK | Cytokinetics, Incorporated | 7.76B | -1.99% | 1,852,696 | 87.21M |
| 29 | MRUS | Merus N.V. | 7.28B | -0.06% | 2,208,839 | 56.61M |
| 30 | AXSM | Axsome Therapeutics, Inc. | 7.22B | -2.36% | 821,250 | 561.26M |
| 31 | CDTX | Cidara Therapeutics, Inc. | 6.90B | 0.24% | 1,809,423 | 302.00K |
| 32 | CAI | Caris Life Sciences, Inc. | 6.78B | 0.54% | 2,175,614 | 649.06M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.72B | -2.41% | 637,121 | 174.33M |
| 34 | PCVX | Vaxcyte, Inc. | 6.24B | -1.90% | 1,390,430 | - |
| 35 | PTCT | PTC Therapeutics, Inc. | 6.14B | 1.14% | 1,474,044 | 1.78B |
| 36 | KRYS | Krystal Biotech, Inc. | 5.92B | 0.06% | 151,654 | 373.16M |
| 37 | COGT | Cogent Biosciences, Inc. | 5.28B | -0.69% | 4,272,736 | - |
| 38 | ARWR | Arrowhead Pharmaceuticals, Inc. | 5.27B | -2.26% | 3,832,951 | 572.98M |
| 39 | PTGX | Protagonist Therapeutics, Inc. | 5.26B | -1.09% | 789,451 | 209.22M |
| 40 | ACLX | Arcellx, Inc. | 5.18B | -0.06% | 847,509 | 35.90M |
| 41 | LEGN | Legend Biotech Corporation | 5.08B | -1.68% | 2,944,105 | 909.05M |
| 42 | CRSP | CRISPR Therapeutics AG | 4.70B | -2.84% | 2,373,209 | 38.34M |
| 43 | KYMR | Kymera Therapeutics, Inc. | 4.65B | -0.29% | 648,464 | 43.74M |
| 44 | AKRO | Akero Therapeutics, Inc. | 4.46B | -0.20% | 1,213,782 | - |
| 45 | TGTX | TG Therapeutics, Inc. | 4.45B | 0.40% | 2,277,664 | 531.90M |
| 46 | CELC | Celcuity Inc. | 4.35B | -0.24% | 752,030 | - |
| 47 | APGE | Apogee Therapeutics, Inc. | 4.28B | -0.72% | 605,319 | - |
| 48 | NAMS | NewAmsterdam Pharma Company N.V. | 4.28B | -2.36% | 1,306,906 | 35.24M |
| 49 | PRAX | Praxis Precision Medicines, Inc. | 4.10B | -13.33% | 2,487,167 | 7.46M |
| 50 | CNTA | Centessa Pharmaceuticals plc | 4.02B | -1.61% | 1,369,989 | 15.00M |
| 51 | IMVT | Immunovant, Inc. | 3.99B | -1.60% | 1,112,469 | - |
| 52 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.98B | -2.17% | 972,333 | 1.54M |
| 53 | ADMA | ADMA Biologics, Inc. | 3.89B | 2.57% | 3,496,343 | 488.56M |
| 54 | SRRK | Scholar Rock Holding Corporation | 3.88B | -4.21% | 1,937,548 | - |
| 55 | ACAD | ACADIA Pharmaceuticals Inc. | 3.87B | -0.87% | 1,148,119 | 1.05B |
| 56 | VKTX | Viking Therapeutics, Inc. | 3.87B | -4.91% | 3,728,267 | - |
| 57 | BLTE | Belite Bio, Inc | 3.81B | -9.29% | 146,477 | - |
| 58 | MIRM | Mirum Pharmaceuticals, Inc. | 3.55B | -1.81% | 416,055 | 471.79M |
| 59 | IRON | Disc Medicine, Inc. | 3.41B | -0.43% | 556,349 | - |
| 60 | ARQT | Arcutis Biotherapeutics, Inc. | 3.35B | -2.01% | 2,875,184 | 317.93M |
| 61 | MLYS | Mineralys Therapeutics, Inc. | 3.31B | -0.59% | 1,616,546 | - |
| 62 | CGON | CG Oncology, Inc. | 3.28B | -4.44% | 591,860 | 2.17M |
| 63 | TARS | Tarsus Pharmaceuticals, Inc. | 3.27B | -0.17% | 408,614 | 366.10M |
| 64 | XENE | Xenon Pharmaceuticals Inc. | 3.11B | -0.93% | 776,235 | 7.50M |
| 65 | TVTX | Travere Therapeutics, Inc. | 3.11B | -1.98% | 1,556,788 | 435.83M |
| 66 | TLX | Telix Pharmaceuticals Limited | 3.04B | -2.99% | 100,862 | 664.23M |
| 67 | AAPG | Ascentage Pharma Group International | 3.02B | -2.86% | 5,595 | 54.52M |
| 68 | RARE | Ultragenyx Pharmaceutical Inc. | 3.00B | -2.13% | 1,028,258 | 630.60M |
| 69 | FOLD | Amicus Therapeutics, Inc. | 2.92B | -2.88% | 3,454,955 | 598.70M |
| 70 | IDYA | IDEAYA Biosciences, Inc. | 2.91B | 0.09% | 1,001,105 | 214.83M |
| 71 | DYN | Dyne Therapeutics, Inc. | 2.87B | -2.33% | 2,034,156 | - |
| 72 | VRDN | Viridian Therapeutics, Inc. | 2.81B | 2.75% | 2,313,670 | 70.79M |
| 73 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.80B | 1.16% | 1,016,992 | 578.20M |
| 74 | DNLI | Denali Therapeutics Inc. | 2.52B | 1.42% | 1,411,506 | - |
| 75 | OCUL | Ocular Therapeutix, Inc. | 2.50B | -3.14% | 2,657,465 | 55.78M |
| 76 | ADPT | Adaptive Biotechnologies Corporation | 2.49B | 7.72% | 3,960,603 | 252.75M |
| 77 | LQDA | Liquidia Corporation | 2.48B | -3.64% | 2,416,487 | 69.22M |
| 78 | APLS | Apellis Pharmaceuticals, Inc. | 2.47B | 0.46% | 2,274,527 | 1.02B |
| 79 | SLNO | Soleno Therapeutics, Inc. | 2.41B | -4.36% | 1,530,540 | 98.68M |
| 80 | NUVB | Nuvation Bio Inc. | 2.40B | -1.96% | 20,244,309 | 26.75M |
| 81 | EWTX | Edgewise Therapeutics, Inc. | 2.36B | -0.40% | 861,088 | - |
| 82 | TERN | Terns Pharmaceuticals, Inc. | 2.35B | -3.72% | 3,404,655 | - |
| 83 | RCUS | Arcus Biosciences, Inc. | 2.29B | 5.00% | 2,127,570 | 240.00M |
| 84 | ZLAB | Zai Lab Limited | 2.24B | -1.41% | 1,195,909 | 441.63M |
| 85 | GPCR | Structure Therapeutics Inc. | 2.08B | -5.94% | 1,406,461 | - |
| 86 | BEAM | Beam Therapeutics Inc. | 2.03B | -1.81% | 1,614,760 | 55.70M |
| 87 | GLPG | Galapagos NV | 2.02B | -0.82% | 136,606 | 336.64M |
| 88 | RXRX | Recursion Pharmaceuticals, Inc. | 2.01B | -4.47% | 38,736,874 | 43.69M |
| 89 | AUPH | Aurinia Pharmaceuticals Inc. | 2.00B | -0.39% | 1,319,284 | 265.81M |
| 90 | IBRX | ImmunityBio, Inc. | 1.99B | -5.61% | 11,674,744 | 82.56M |
| 91 | IMCR | Immunocore Holdings plc | 1.97B | 0.93% | 785,566 | 379.59M |
| 92 | HRMY | Harmony Biosciences Holdings, Inc. | 1.92B | 0.24% | 897,961 | 825.94M |
| 93 | VCEL | Vericel Corporation | 1.91B | -2.82% | 402,884 | 258.72M |
| 94 | MESO | Mesoblast Limited | 1.91B | -3.57% | 162,210 | 17.20M |
| 95 | ZBIO | Zenas BioPharma, Inc. | 1.87B | -6.22% | 328,079 | 15.00M |
| 96 | SYRE | Spyre Therapeutics, Inc. | 1.82B | -3.42% | 627,641 | - |
| 97 | ZYME | Zymeworks Inc. | 1.78B | 5.40% | 1,534,261 | 134.48M |
| 98 | VERA | Vera Therapeutics, Inc. | 1.78B | -2.38% | 1,231,706 | - |
| 99 | SION | Sionna Therapeutics, Inc. | 1.74B | 1.56% | 156,993 | - |
| 100 | QURE | uniQure N.V. | 1.74B | -0.18% | 2,704,432 | 15.75M |
| 101 | DNTH | Dianthus Therapeutics, Inc. | 1.73B | -0.98% | 816,981 | 3.08M |
| 102 | SRPT | Sarepta Therapeutics, Inc. | 1.73B | 0.55% | 4,634,565 | 2.41B |
| 103 | JANX | Janux Therapeutics, Inc. | 1.72B | -0.76% | 694,021 | 10.00M |
| 104 | MAZE | Maze Therapeutics, Inc. | 1.71B | 0.08% | 356,842 | 2.50M |
| 105 | CLDX | Celldex Therapeutics, Inc. | 1.67B | 0.60% | 656,723 | 2.60M |
| 106 | IMNM | Immunome, Inc. | 1.61B | -1.02% | 849,805 | 9.68M |
| 107 | STOK | Stoke Therapeutics, Inc. | 1.60B | -1.93% | 611,903 | 205.63M |
| 108 | INVA | Innoviva, Inc. | 1.58B | -0.52% | 739,127 | 388.52M |
| 109 | PHVS | Pharvaris N.V. | 1.57B | -1.39% | 426,030 | - |
| 110 | NRIX | Nurix Therapeutics, Inc. | 1.55B | 6.98% | 2,372,393 | 83.69M |
| 111 | MNKD | MannKind Corporation | 1.53B | -0.60% | 2,468,112 | 313.79M |
| 112 | OLMA | Olema Pharmaceuticals, Inc. | 1.51B | 13.28% | 12,269,442 | - |
| 113 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.49B | -5.24% | 1,030,432 | -665.00K |
| 114 | SNDX | Syndax Pharmaceuticals, Inc. | 1.48B | 2.03% | 3,106,690 | 111.30M |
| 115 | AGIO | Agios Pharmaceuticals, Inc. | 1.43B | 9.98% | 7,665,686 | 44.79M |
| 116 | PGEN | Precigen, Inc. | 1.38B | -7.58% | 5,304,638 | 6.31M |
| 117 | TRVI | Trevi Therapeutics, Inc. | 1.37B | -3.53% | 1,649,469 | - |
| 118 | UPB | Upstream Bio, Inc. | 1.35B | 0.08% | 402,303 | 2.80M |
| 119 | ARDX | Ardelyx, Inc. | 1.35B | -0.36% | 2,899,738 | 398.23M |
| 120 | ORKA | Oruka Therapeutics, Inc. | 1.31B | -4.49% | 412,357 | - |
| 121 | RAPP | Rapport Therapeutics, Inc. | 1.28B | -0.11% | 444,482 | - |
| 122 | BHVN | Biohaven Ltd. | 1.28B | 1.80% | 5,033,576 | - |
| 123 | ELVN | Enliven Therapeutics, Inc. | 1.26B | -3.76% | 352,132 | - |
| 124 | IMTX | Immatics N.V. | 1.23B | -2.23% | 423,801 | 99.45M |
| 125 | MBX | MBX Biosciences, Inc. | 1.21B | -1.31% | 729,754 | - |
| 126 | TNGX | Tango Therapeutics, Inc. | 1.20B | 7.42% | 3,403,334 | 66.50M |
| 127 | URGN | UroGen Pharma Ltd. | 1.16B | -1.70% | 723,213 | 96.52M |
| 128 | INBX | Inhibrx Biosciences, Inc. | 1.16B | -2.80% | 313,455 | 1.40M |
| 129 | CVAC | CureVac N.V. | 1.15B | -1.92% | 1,162,276 | 599.54M |
| 130 | PHAR | Pharming Group N.V. | 1.15B | 0.87% | 17,932 | 362.27M |
| 131 | XERS | Xeris Biopharma Holdings, Inc. | 1.13B | -3.53% | 1,738,857 | 266.14M |
| 132 | WVE | Wave Life Sciences Ltd. | 1.13B | -1.82% | 2,899,069 | 109.23M |
| 133 | EYPT | EyePoint Pharmaceuticals, Inc. | 1.13B | -4.48% | 1,336,874 | 42.34M |
| 134 | SVRA | Savara Inc. | 1.13B | 1.52% | 2,407,461 | - |
| 135 | NKTR | Nektar Therapeutics | 1.12B | -8.68% | 735,832 | 62.60M |
| 136 | TYRA | Tyra Biosciences, Inc. | 1.12B | 26.35% | 1,884,078 | - |
| 137 | ORIC | ORIC Pharmaceuticals, Inc. | 1.12B | - | 1,606,572 | - |
| 138 | XNCR | Xencor, Inc. | 1.11B | -1.24% | 549,638 | 150.13M |
| 139 | OCS | Oculis Holding AG | 1.11B | -0.31% | 96,850 | 992.00K |
| 140 | RLAY | Relay Therapeutics, Inc. | 1.11B | 0.63% | 2,147,286 | 8.36M |
| 141 | TSHA | Taysha Gene Therapies, Inc. | 1.09B | -0.50% | 3,677,247 | 6.31M |
| 142 | PVLA | Palvella Therapeutics, Inc. | 1.08B | -5.54% | 358,367 | - |
| 143 | MNMD | Mind Medicine (MindMed) Inc. | 1.07B | -0.46% | 1,424,658 | - |
| 144 | SEPN | Septerna, Inc. | 1.06B | 2.90% | 276,952 | 22.05M |
| 145 | ANAB | AnaptysBio, Inc. | 1.04B | 1.76% | 493,602 | 169.47M |
| 146 | KOD | Kodiak Sciences Inc. | 1.04B | 0.31% | 731,801 | - |
| 147 | ABCL | AbCellera Biologics Inc. | 1.02B | -5.54% | 4,095,153 | 35.33M |
| 148 | NBTX | Nanobiotix S.A. | 1.01B | -5.91% | 36,612 | 11.93M |
| 149 | NVAX | Novavax, Inc. | 1.01B | -1.89% | 3,908,975 | 1.06B |
| 150 | PHAT | Phathom Pharmaceuticals, Inc. | 1.00B | -2.91% | 475,696 | 147.19M |
| 151 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 974.26M | -3.94% | 76,952 | - |
| 152 | MDXG | MiMedx Group, Inc. | 968.59M | 0.93% | 1,186,030 | 393.44M |
| 153 | KURA | Kura Oncology, Inc. | 955.45M | -3.00% | 1,627,643 | 104.03M |
| 154 | NTLA | Intellia Therapeutics, Inc. | 931.27M | -2.43% | 6,188,193 | 57.53M |
| 155 | MLTX | MoonLake Immunotherapeutics | 927.86M | -3.99% | 1,346,363 | - |
| 156 | FTRE | Fortrea Holdings Inc. | 927.70M | - | 704,251 | 2.76B |
| 157 | TBPH | Theravance Biopharma, Inc. | 907.04M | 0.96% | 526,734 | 80.33M |
| 158 | RZLT | Rezolute, Inc. | 894.82M | -5.02% | 1,020,925 | - |
| 159 | BCAX | Bicara Therapeutics Inc. | 886.37M | 6.59% | 807,686 | - |
| 160 | GLUE | Monte Rosa Therapeutics, Inc. | 880.39M | -4.38% | 827,771 | 181.54M |
| 161 | MRVI | Maravai LifeSciences Holdings, Inc. | 874.52M | -2.29% | 2,172,571 | 192.44M |
| 162 | GHRS | GH Research PLC | 867.79M | -2.71% | 254,074 | - |
| 163 | LENZ | LENZ Therapeutics, Inc. | 867.36M | -2.39% | 957,520 | 17.50M |
| 164 | IOVA | Iovance Biotherapeutics, Inc. | 865.39M | -3.54% | 8,541,258 | 250.43M |
| 165 | CMPX | Compass Therapeutics, Inc. | 862.63M | -1.02% | 1,036,615 | 850.00K |
| 166 | SANA | Sana Biotechnology, Inc. | 860.36M | -5.00% | 4,111,607 | - |
| 167 | DAWN | Day One Biopharmaceuticals, Inc. | 851.18M | -1.43% | 1,963,899 | 133.67M |
| 168 | AVBP | ArriVent BioPharma, Inc. | 828.10M | 0.15% | 192,310 | - |
| 169 | ABUS | Arbutus Biopharma Corporation | 807.76M | -1.64% | 1,413,620 | 14.61M |
| 170 | RIGL | Rigel Pharmaceuticals, Inc. | 795.75M | 5.18% | 695,502 | 282.08M |
| 171 | ERAS | Erasca, Inc. | 788.72M | 0.72% | 1,646,790 | - |
| 172 | ATAI | Atai Beckley N.V. | 784.48M | -4.19% | 6,697,690 | 3.02M |
| 173 | VIR | Vir Biotechnology, Inc. | 773.54M | 2.21% | 1,784,055 | 16.86M |
| 174 | CRMD | CorMedix Inc. | 765.83M | -3.09% | 3,074,730 | 214.30M |
| 175 | VSTM | Verastem, Inc. | 757.15M | 5.83% | 2,463,133 | 13.38M |
| 176 | RAPT | RAPT Therapeutics, Inc. | 754.84M | -3.81% | 303,790 | - |
| 177 | VALN | Valneva SE | 747.09M | -1.38% | 23,120 | 211.09M |
| 178 | ALMS | Alumis Inc. | 722.40M | 5.33% | 1,619,789 | 22.12M |
| 179 | GOSS | Gossamer Bio, Inc. | 719.83M | -0.96% | 2,945,115 | 44.05M |
| 180 | ATXS | Astria Therapeutics, Inc. | 710.71M | 0.08% | 519,905 | 706.00K |
| 181 | ARVN | Arvinas, Inc. | 707.75M | -4.42% | 2,033,287 | 312.30M |
| 182 | REPL | Replimune Group, Inc. | 706.77M | 0.22% | 1,390,791 | - |
| 183 | GERN | Geron Corporation | 702.19M | 1.85% | 12,195,183 | 183.40M |
| 184 | VTYX | Ventyx Biosciences, Inc. | 685.76M | 1.48% | 1,917,260 | - |
| 185 | GYRE | Gyre Therapeutics, Inc. | 680.77M | -1.06% | 39,776 | 107.27M |
| 186 | SPRY | ARS Pharmaceuticals, Inc. | 665.25M | -5.08% | 1,773,219 | 142.77M |
| 187 | KALV | KalVista Pharmaceuticals, Inc. | 658.11M | -5.03% | 1,131,806 | 1.43M |
| 188 | PRME | Prime Medicine, Inc. | 653.27M | -0.81% | 5,060,340 | 5.98M |
| 189 | LXEO | Lexeo Therapeutics, Inc. | 650.32M | -1.98% | 1,349,534 | - |
| 190 | CTMX | CytomX Therapeutics, Inc. | 638.77M | 3.86% | 1,864,519 | 113.63M |
| 191 | CRVS | Corvus Pharmaceuticals, Inc. | 635.54M | -4.38% | 678,126 | - |
| 192 | PROK | ProKidney Corp. | 628.74M | -9.91% | 1,122,009 | 744.00K |
| 193 | ANNX | Annexon, Inc. | 617.99M | 5.17% | 8,286,346 | - |
| 194 | FULC | Fulcrum Therapeutics, Inc. | 598.55M | -3.91% | 832,690 | 80.00M |
| 195 | MGTX | MeiraGTx Holdings plc | 598.05M | -1.98% | 506,614 | 27.42M |
| 196 | FDMT | 4D Molecular Therapeutics, Inc. | 590.78M | -4.26% | 884,112 | 120.00K |
| 197 | YDES | YD Bio Limited | 587.87M | -10.11% | 69,680 | 510.36K |
| 198 | OMER | Omeros Corporation | 583.51M | 0.12% | 1,271,126 | - |
| 199 | ASMB | Assembly Biosciences, Inc. | 580.96M | -3.34% | 149,567 | 37.19M |
| 200 | MPLT | MapLight Therapeutics, Inc. | 579.99M | -8.97% | 136,597 | - |
| 201 | IVA | Inventiva S.A. | 579.66M | -6.05% | 108,592 | 19.93M |
| 202 | EVMN | Evommune, Inc. | 562.75M | -3.01% | 92,099 | 3.00M |
| 203 | IVVD | Invivyd, Inc. | 559.49M | -4.00% | 4,905,521 | 50.04M |
| 204 | MNPR | Monopar Therapeutics Inc. | 554.65M | - | 91,378 | - |
| 205 | RGNX | REGENXBIO Inc. | 550.27M | -0.55% | 444,694 | 161.32M |
| 206 | PRTA | Prothena Corporation plc | 540.99M | 0.60% | 457,797 | 11.79M |
| 207 | NAGE | Niagen Bioscience, Inc. | 537.40M | -2.75% | 774,569 | 124.71M |
| 208 | JBIO | Jade Biosciences, Inc. | 528.13M | -7.87% | 144,098 | - |
| 209 | CGEM | Cullinan Therapeutics, Inc. | 515.14M | 3.20% | 1,080,072 | - |
| 210 | KROS | Keros Therapeutics, Inc. | 512.44M | -0.24% | 945,463 | 246.72M |
| 211 | ZVRA | Zevra Therapeutics, Inc. | 509.49M | -6.51% | 1,019,780 | 84.39M |
| 212 | ADCT | ADC Therapeutics SA | 494.27M | -0.75% | 640,091 | 75.21M |
| 213 | NBP | NovaBridge Biosciences | 482.96M | -7.51% | 743,320 | - |
| 214 | DBVT | DBV Technologies S.A. | 482.53M | -3.71% | 69,213 | 5.50M |
| 215 | LXRX | Lexicon Pharmaceuticals, Inc. | 479.69M | -8.97% | 2,747,858 | 70.86M |
| 216 | ALT | Altimmune, Inc. | 466.41M | -2.61% | 2,988,854 | 20.00K |
| 217 | IMRX | Immuneering Corporation | 451.34M | -2.51% | 941,060 | - |
| 218 | DSGN | Design Therapeutics, Inc. | 448.30M | 7.22% | 691,113 | - |
| 219 | DRUG | Bright Minds Biosciences Inc. | 446.21M | -1.46% | 92,614 | - |
| 220 | BNTC | Benitec Biopharma Inc. | 444.95M | 0.31% | 219,443 | - |
| 221 | DNA | Ginkgo Bioworks Holdings, Inc. | 444.46M | -1.14% | 1,057,435 | 180.61M |
| 222 | ANRO | Alto Neuroscience, Inc. | 439.59M | -8.94% | 444,350 | - |
| 223 | BCYC | Bicycle Therapeutics plc | 428.00M | -1.28% | 423,029 | 28.34M |
| 224 | ENGN | enGene Holdings Inc. | 426.22M | -2.37% | 538,865 | - |
| 225 | ABSI | Absci Corporation | 416.53M | -3.15% | 5,992,863 | 2.82M |
| 226 | LCTX | Lineage Cell Therapeutics, Inc. | 404.69M | -2.34% | 1,689,880 | 10.82M |
| 227 | LBRX | LB Pharmaceuticals Inc | 399.47M | -0.54% | 49,776 | - |
| 228 | NMRA | Neumora Therapeutics, Inc. | 394.33M | -7.09% | 1,199,413 | - |
| 229 | XOMA | XOMA Royalty Corporation | 392.42M | -4.40% | 68,932 | 47.11M |
| 230 | VTVT | vTv Therapeutics Inc. | 391.25M | -2.20% | 11,785 | 17.00K |
| 231 | PRTC | PureTech Health plc | 387.27M | 1.61% | 2,689 | 6.39M |
| 232 | DMAC | DiaMedica Therapeutics Inc. | 376.00M | -1.10% | 518,047 | - |
| 233 | GALT | Galectin Therapeutics Inc. | 370.07M | - | 275,328 | - |
| 234 | LYEL | Lyell Immunopharma, Inc. | 369.83M | 1.22% | 22,275 | 41.00K |
| 235 | FBRX | Forte Biosciences, Inc. | 364.68M | 9.35% | 305,081 | - |
| 236 | CLLS | Cellectis S.A. | 358.87M | 8.64% | 377,111 | 82.55M |
| 237 | CTNM | Contineum Therapeutics, Inc. | 356.61M | -1.69% | 638,899 | - |
| 238 | PEPG | PepGen Inc. | 349.93M | -7.96% | 743,040 | - |
| 239 | PALI | Palisade Bio, Inc. | 348.67M | 7.83% | 4,981,101 | - |
| 240 | SLDB | Solid Biosciences Inc. | 347.48M | -0.45% | 967,736 | - |
| 241 | OCGN | Ocugen, Inc. | 346.68M | -2.63% | 3,634,869 | 5.37M |
| 242 | AURA | Aura Biosciences, Inc. | 339.74M | -0.93% | 237,194 | - |
| 243 | TECX | Tectonic Therapeutic, Inc. | 338.02M | -3.73% | 405,012 | - |
| 244 | ENTA | Enanta Pharmaceuticals, Inc. | 337.88M | -0.08% | 278,094 | 65.32M |
| 245 | TRDA | Entrada Therapeutics, Inc. | 328.85M | 5.04% | 268,347 | 61.52M |
| 246 | AUTL | Autolus Therapeutics plc | 327.36M | -3.15% | 1,999,549 | 51.13M |
| 247 | KYTX | Kyverna Therapeutics, Inc. | 325.84M | -9.60% | 658,519 | - |
| 248 | XFOR | X4 Pharmaceuticals, Inc. | 323.52M | 1.37% | 644,566 | 33.98M |
| 249 | AVTX | Avalo Therapeutics, Inc. | 321.70M | 0.85% | 337,736 | 192.00K |
| 250 | EPRX | Eupraxia Pharmaceuticals Inc. | 316.96M | 0.16% | 38,219 | - |
| 251 | RLMD | Relmada Therapeutics, Inc. | 316.80M | 3.35% | 1,179,783 | - |
| 252 | NGNE | Neurogene Inc. | 315.99M | -2.81% | 320,620 | 925.00K |
| 253 | TENX | Tenax Therapeutics, Inc. | 312.59M | 5.26% | 69,382 | - |
| 254 | RCKT | Rocket Pharmaceuticals, Inc. | 307.35M | -1.39% | 2,869,182 | - |
| 255 | SLN | Silence Therapeutics plc | 299.94M | -1.24% | 247,607 | 25.83M |
| 256 | DRTS | Alpha Tau Medical Ltd. | 295.10M | -5.71% | 80,813 | - |
| 257 | CYBN | Cybin Inc. | 291.94M | -1.35% | 570,005 | - |
| 258 | LRMR | Larimar Therapeutics, Inc. | 288.44M | -2.88% | 1,327,528 | - |
| 259 | ACIU | AC Immune SA | 287.92M | -6.73% | 265,249 | 5.48M |
| 260 | VNDA | Vanda Pharmaceuticals Inc. | 286.03M | -5.84% | 1,148,006 | 212.07M |
| 261 | MREO | Mereo BioPharma Group plc | 284.85M | -1.10% | 1,298,073 | 500.00K |
| 262 | ALDX | Aldeyra Therapeutics, Inc. | 284.57M | -2.67% | 560,401 | - |
| 263 | PYXS | Pyxis Oncology, Inc. | 282.06M | -0.88% | 778,199 | 2.82M |
| 264 | ALLO | Allogene Therapeutics, Inc. | 278.67M | -1.59% | 2,611,462 | 22.00K |
| 265 | AVXL | Anavex Life Sciences Corp. | 272.28M | -11.94% | 5,822,946 | - |
| 266 | FENC | Fennec Pharmaceuticals Inc. | 268.28M | -3.97% | 152,662 | 38.79M |
| 267 | NAUT | Nautilus Biotechnology, Inc. | 267.14M | -12.24% | 564,437 | - |
| 268 | ACRS | Aclaris Therapeutics, Inc. | 261.11M | -2.03% | 860,215 | 15.74M |
| 269 | CAPR | Capricor Therapeutics, Inc. | 260.14M | -1.39% | 916,495 | 11.13M |
| 270 | ARMP | Armata Pharmaceuticals, Inc. | 259.76M | -2.05% | 48,896 | 5.05M |
| 271 | FHTX | Foghorn Therapeutics Inc. | 259.00M | -5.76% | 362,343 | 24.52M |
| 272 | CBIO | Crescent Biopharma, Inc. | 255.71M | 0.38% | 83,744 | - |
| 273 | IMMP | Immutep Limited | 252.30M | -1.17% | 78,402 | 3.31M |
| 274 | OBIO | Orchestra BioMed Holdings, Inc. | 250.14M | -4.94% | 464,107 | 2.82M |
| 275 | TARA | Protara Therapeutics, Inc. | 248.50M | -4.02% | 1,032,065 | - |
| 276 | PBYI | Puma Biotechnology, Inc. | 243.89M | -0.92% | 330,627 | 212.00M |
| 277 | CADL | Candel Therapeutics, Inc. | 242.65M | - | 802,938 | - |
| 278 | EDIT | Editas Medicine, Inc. | 241.12M | -1.98% | 2,093,433 | 46.38M |
| 279 | OABI | OmniAb, Inc. | 239.69M | 0.91% | 459,442 | 21.09M |
| 280 | ZURA | Zura Bio Limited | 238.64M | -5.17% | 303,264 | - |
| 281 | SGMT | Sagimet Biosciences Inc. | 236.43M | -7.39% | 328,220 | - |
| 282 | MIST | Milestone Pharmaceuticals Inc. | 234.66M | -0.86% | 4,024,829 | - |
| 283 | AVIR | Atea Pharmaceuticals, Inc. | 234.38M | -4.76% | 764,308 | - |
| 284 | CCCC | C4 Therapeutics, Inc. | 230.66M | -4.80% | 1,753,795 | 30.11M |
| 285 | ABEO | Abeona Therapeutics Inc. | 228.69M | 0.48% | 1,844,217 | 400.00K |
| 286 | VYGR | Voyager Therapeutics, Inc. | 227.40M | -1.32% | 398,144 | 31.32M |
| 287 | BDTX | Black Diamond Therapeutics, Inc. | 217.07M | -2.06% | 999,970 | 70.00M |
| 288 | PRQR | ProQR Therapeutics N.V. | 217.01M | 1.48% | 450,598 | 18.86M |
| 289 | MDWD | MediWound Ltd. | 216.17M | -5.60% | 270,191 | 20.93M |
| 290 | HUMA | Humacyte, Inc. | 209.74M | -4.27% | 6,447,060 | 1.57M |
| 291 | SLS | SELLAS Life Sciences Group, Inc. | 207.97M | -3.95% | 1,993,957 | - |
| 292 | CABA | Cabaletta Bio, Inc. | 206.97M | -4.02% | 3,110,116 | - |
| 293 | ACHV | Achieve Life Sciences, Inc. | 206.55M | -10.19% | 1,044,002 | - |
| 294 | AARD | Aardvark Therapeutics, Inc. | 205.32M | -9.85% | 109,392 | - |
| 295 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 205.20M | -1.10% | 276,466 | - |
| 296 | MCRB | Seres Therapeutics, Inc. | 196.31M | -24.21% | 1,822,136 | 351.00K |
| 297 | HRTX | Heron Therapeutics, Inc. | 193.45M | -3.21% | 2,764,701 | 155.10M |
| 298 | TNYA | Tenaya Therapeutics, Inc. | 193.15M | -2.52% | 2,299,098 | - |
| 299 | TLSA | Tiziana Life Sciences Ltd | 191.90M | -4.44% | 143,917 | - |
| 300 | RANI | Rani Therapeutics Holdings, Inc. | 187.13M | -12.00% | 3,212,705 | 1.20M |
| 301 | RNAC | Cartesian Therapeutics, Inc. | 185.93M | - | 114,992 | 1.09M |
| 302 | TNXP | Tonix Pharmaceuticals Holding Corp. | 184.19M | -6.46% | 1,035,485 | 10.30M |
| 303 | SABS | SAB Biotherapeutics, Inc. | 180.91M | -0.78% | 223,924 | 114.70K |
| 304 | GUTS | Fractyl Health, Inc. | 176.79M | -3.01% | 1,108,892 | 3.00K |
| 305 | CNTB | Connect Biopharma Holdings Limited | 176.10M | - | 928,471 | 762.00K |
| 306 | VTGN | Vistagen Therapeutics, Inc. | 175.75M | -1.11% | 1,695,166 | 721.00K |
| 307 | GNLX | Genelux Corporation | 174.55M | -7.20% | 336,894 | 8.00K |
| 308 | IPHA | Innate Pharma S.A. | 170.59M | 1.68% | 51,981 | 14.84M |
| 309 | ARCT | Arcturus Therapeutics Holdings Inc. | 167.63M | -2.32% | 1,010,219 | 97.60M |
| 310 | CAMP | Camp4 Therapeutics Corporation | 164.55M | -5.39% | 73,942 | 3.80M |
| 311 | CRBU | Caribou Biosciences, Inc. | 163.57M | -3.85% | 1,531,325 | 9.30M |
| 312 | ETHZ | ETHZilla Corporation | 159.88M | -8.80% | 973,749 | 4.11M |
| 313 | NVCT | Nuvectis Pharma, Inc. | 150.87M | -1.34% | 70,259 | - |
| 314 | MOLN | Molecular Partners AG | 149.76M | -1.67% | 5,359 | 856.30K |
| 315 | AGEN | Agenus Inc. | 145.90M | 2.14% | 372,944 | 106.83M |
| 316 | ANIX | Anixa Biosciences, Inc. | 144.83M | 1.15% | 233,077 | - |
| 317 | CGEN | Compugen Ltd. | 142.17M | -5.00% | 241,657 | 6.90M |
| 318 | CDXS | Codexis, Inc. | 141.81M | -3.09% | 878,085 | 52.93M |
| 319 | ACTU | Actuate Therapeutics, Inc. | 141.55M | 4.10% | 208,375 | - |
| 320 | VOR | Vor Biopharma Inc. | 140.02M | -12.28% | 1,087,277 | - |
| 321 | PLX | Protalix BioTherapeutics, Inc. | 139.93M | -1.69% | 602,570 | 61.84M |
| 322 | ELTX | Elicio Therapeutics, Inc. | 139.80M | -1.23% | 100,981 | - |
| 323 | EXOZ | eXoZymes, Inc. | 138.98M | 2.44% | 5,041 | -700.00 |
| 324 | MRSN | Mersana Therapeutics, Inc. | 137.29M | -0.36% | 120,988 | 33.18M |
| 325 | IMMX | Immix Biopharma, Inc. | 134.98M | -4.96% | 551,312 | - |
| 326 | IRD | Opus Genetics, Inc. | 133.10M | 3.76% | 764,776 | 14.63M |
| 327 | CHRS | Coherus Oncology, Inc. | 132.96M | -5.17% | 1,151,738 | 277.73M |
| 328 | CRDF | Cardiff Oncology, Inc. | 132.03M | -2.00% | 850,069 | 501.00K |
| 329 | PRLD | Prelude Therapeutics Incorporated | 131.84M | -4.19% | 296,794 | 10.50M |
| 330 | ALEC | Alector, Inc. | 130.98M | -1.64% | 2,111,675 | 69.05M |
| 331 | SGMO | Sangamo Therapeutics, Inc. | 129.55M | -1.81% | 4,671,520 | 32.88M |
| 332 | KLRS | Kalaris Therapeutics, Inc. | 129.05M | 3.29% | 348,875 | - |
| 333 | SPRO | Spero Therapeutics, Inc. | 127.33M | -5.04% | 434,918 | 40.55M |
| 334 | SAVA | Cassava Sciences, Inc. | 127.05M | -4.36% | 1,288,014 | - |
| 335 | ACOG | Alpha Cognition Inc. | 126.76M | -1.52% | 47,286 | 7.43M |
| 336 | NBY | NovaBay Pharmaceuticals, Inc. | 124.75M | -1.00% | 117,035 | 10.30M |
| 337 | COYA | Coya Therapeutics, Inc. | 123.79M | 2.18% | 259,853 | 3.99M |
| 338 | NKTX | Nkarta, Inc. | 122.88M | -3.35% | 686,316 | - |
| 339 | STTK | Shattuck Labs, Inc. | 122.13M | -1.53% | 120,539 | 1.00M |
| 340 | CNTX | Context Therapeutics Inc. | 121.51M | -2.56% | 544,651 | - |
| 341 | DTIL | Precision BioSciences, Inc. | 119.88M | 3.32% | 170,270 | 698.00K |
| 342 | INO | Inovio Pharmaceuticals, Inc. | 118.86M | -2.81% | 830,138 | 182.34K |
| 343 | CLYM | Climb Bio, Inc. | 117.96M | -5.98% | 532,536 | - |
| 344 | SRZN | Surrozen, Inc. | 117.77M | 1.78% | 91,318 | 3.60M |
| 345 | CGTX | Cognition Therapeutics, Inc. | 117.40M | -4.32% | 1,163,827 | - |
| 346 | ENTX | Entera Bio Ltd. | 117.35M | -3.02% | 132,851 | 124.00K |
| 347 | FATE | Fate Therapeutics, Inc. | 115.35M | -4.76% | 1,206,575 | 7.14M |
| 348 | IKT | Inhibikase Therapeutics, Inc. | 115.02M | -1.92% | 182,347 | 1.00 |
| 349 | NTHI | NeOnc Technologies Holdings, Inc. | 113.61M | -11.89% | 38,055 | 59.99K |
| 350 | QNCX | Quince Therapeutics, Inc. | 113.59M | 5.70% | 659,074 | - |
| 351 | UNCY | Unicycive Therapeutics, Inc. | 113.26M | -4.70% | 327,750 | - |
| 352 | GLSI | Greenwich LifeSciences, Inc. | 113.05M | 0.37% | 52,607 | - |
| 353 | SPRB | Spruce Biosciences, Inc. | 109.83M | -7.56% | 214,727 | 697.00K |
| 354 | SEER | Seer, Inc. | 108.23M | -3.00% | 123,151 | 16.38M |
| 355 | ONCY | Oncolytics Biotech Inc. | 105.24M | -4.66% | 786,235 | - |
| 356 | ELDN | Eledon Pharmaceuticals, Inc. | 104.46M | -10.32% | 2,482,083 | - |
| 357 | GANX | Gain Therapeutics, Inc. | 102.88M | 3.64% | 1,509,267 | - |
| 358 | ANVS | Annovis Bio, Inc. | 102.83M | 14.79% | 3,589,945 | - |
| 359 | SLGL | Sol-Gel Technologies Ltd. | 99.59M | -0.80% | 24,523 | 18.97M |
| 360 | VANI | Vivani Medical, Inc. | 98.49M | -1.46% | 248,840 | - |
| 361 | KPTI | Karyopharm Therapeutics Inc. | 98.21M | -3.68% | 102,864 | 142.53M |
| 362 | ATOS | Atossa Therapeutics, Inc. | 97.14M | -1.52% | 496,951 | - |
| 363 | ORMP | Oramed Pharmaceuticals Inc. | 96.32M | -3.01% | 115,673 | 2.00M |
| 364 | PLRX | Pliant Therapeutics, Inc. | 95.86M | 4.00% | 1,686,121 | - |
| 365 | ATRA | Atara Biotherapeutics, Inc. | 95.32M | -3.78% | 91,058 | 151.93M |
| 366 | ABOS | Acumen Pharmaceuticals, Inc. | 94.49M | 0.65% | 147,691 | - |
| 367 | ZNTL | Zentalis Pharmaceuticals, Inc. | 94.29M | -1.88% | 610,254 | 26.87M |
| 368 | ANEB | Anebulo Pharmaceuticals, Inc. | 94.08M | -0.43% | 7,145 | - |
| 369 | WHWK | Whitehawk Therapeutics, Inc. | 93.79M | -4.78% | 264,907 | 14.38M |
| 370 | ACET | Adicet Bio, Inc. | 93.38M | 0.05% | 1,020,437 | - |
| 371 | ADVM | Adverum Biotechnologies, Inc. | 92.50M | -1.41% | 335,817 | 1.00M |
| 372 | CSBR | Champions Oncology, Inc. | 91.42M | -3.21% | 2,013 | 56.88M |
| 373 | RPTX | Repare Therapeutics Inc. | 90.21M | -2.33% | 4,859,618 | 11.87M |
| 374 | PTHS | Pelthos Therapeutics Inc. | 88.79M | -3.37% | 30,469 | 7.41M |
| 375 | VXRT | Vaxart, Inc. | 87.44M | -6.17% | - | 80.72M |
| 376 | COEP | Coeptis Therapeutics Holdings, Inc. | 87.10M | 2.19% | 58,003 | 501.00K |
| 377 | OVID | Ovid Therapeutics Inc. | 86.88M | -4.69% | 1,120,425 | 6.61M |
| 378 | MGNX | MacroGenics, Inc. | 86.66M | -3.52% | 685,918 | 127.63M |
| 379 | ADAG | Adagene Inc. | 84.84M | -0.55% | 79,098 | 103.20K |
| 380 | OTLK | Outlook Therapeutics, Inc. | 83.51M | -4.08% | 3,460,215 | 1.51M |
| 381 | CRVO | CervoMed Inc. | 83.37M | 4.59% | 139,836 | 6.16M |
| 382 | IMUX | Immunic, Inc. | 82.70M | -3.62% | 1,878,247 | - |
| 383 | TVGN | Tevogen Bio Holdings Inc. | 82.12M | -8.03% | 328,707 | - |
| 384 | HYFT | MindWalk Holdings Corp. | 81.69M | -2.21% | 371,310 | 18.21M |
| 385 | HURA | TuHURA Biosciences, Inc. | 81.24M | -9.43% | 287,757 | - |
| 386 | TIL | Instil Bio, Inc. | 81.18M | -1.89% | 72,849 | - |
| 387 | TTRX | Turn Therapeutics Inc. | 79.80M | -4.24% | 135,758 | - |
| 388 | THAR | Tharimmune, Inc. | 78.85M | -9.64% | 407,069 | - |
| 389 | IFRX | InflaRx N.V. | 77.91M | -8.73% | 1,319,519 | 73.73K |
| 390 | ARTV | Artiva Biotherapeutics, Inc. | 77.81M | -6.49% | 107,695 | 251.00K |
| 391 | IMA | ImageneBio, Inc. | 76.15M | -2.46% | 28,291 | 800.00K |
| 392 | FBIO | Fortress Biotech, Inc. | 75.28M | -2.69% | 333,849 | 62.30M |
| 393 | ALXO | ALX Oncology Holdings Inc. | 73.74M | -7.48% | 167,467 | - |
| 394 | STRO | Sutro Biopharma, Inc. | 72.08M | -6.97% | 1,405,427 | 105.65M |
| 395 | OKYO | OKYO Pharma Limited | 71.84M | -5.45% | 144,859 | - |
| 396 | ACRV | Acrivon Therapeutics, Inc. | 71.09M | -4.24% | 830,421 | - |
| 397 | BMEA | Biomea Fusion, Inc. | 70.70M | -9.09% | 1,569,781 | - |
| 398 | BYSI | BeyondSpring Inc. | 70.18M | -10.77% | 56,534 | 1.88M |
| 399 | PMVP | PMV Pharmaceuticals, Inc. | 69.71M | -3.68% | 133,705 | - |
| 400 | MNOV | MediciNova, Inc. | 69.65M | -0.70% | 39,115 | 257.92K |
| 401 | CBUS | Cibus, Inc. | 68.40M | -0.79% | 199,681 | 3.79M |
| 402 | BCAB | BioAtla, Inc. | 68.20M | - | 1,734,314 | 11.00M |
| 403 | XBIT | XBiotech Inc. | 67.68M | 2.78% | 79,232 | - |
| 404 | PSTV | Plus Therapeutics, Inc. | 67.12M | -0.35% | 24,399,566 | 5.26M |
| 405 | ATYR | aTyr Pharma, Inc. | 63.83M | -3.52% | 4,353,532 | 190.00K |
| 406 | ATHE | Alterity Therapeutics Limited | 63.25M | -3.03% | 9,491 | 3.57M |
| 407 | ABVC | ABVC BioPharma, Inc. | 62.70M | -2.21% | 61,458 | 797.92K |
| 408 | LITS | Lite Strategy, Inc. | 62.54M | -4.49% | 896,762 | - |
| 409 | EQ | Equillium, Inc. | 61.50M | - | 937,447 | 4.39M |
| 410 | ESLA | Estrella Immunopharma, Inc. | 61.18M | -7.43% | 289,407 | - |
| 411 | NTRB | Nutriband Inc. | 60.56M | -2.14% | 25,012 | 2.58M |
| 412 | PYPD | PolyPid Ltd. | 60.38M | 0.83% | 77,073 | - |
| 413 | MGX | Metagenomi, Inc. | 56.70M | -6.21% | 470,446 | 30.91M |
| 414 | KRRO | Korro Bio, Inc. | 56.41M | -6.55% | 623,110 | 7.37M |
| 415 | TCRX | TScan Therapeutics, Inc. | 55.91M | -4.35% | 515,121 | 8.42M |
| 416 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 55.23M | -3.63% | 2,980,982 | - |
| 417 | OSTX | OS Therapies Incorporated | 54.32M | -1.82% | 218,904 | - |
| 418 | ANL | Adlai Nortye Ltd. | 52.77M | -2.05% | 12,610 | 1.94M |
| 419 | ALGS | Aligos Therapeutics, Inc. | 50.83M | 0.36% | 132,191 | 2.65M |
| 420 | JSPR | Jasper Therapeutics, Inc. | 49.25M | -4.86% | 319,593 | - |
| 421 | INKT | MiNK Therapeutics, Inc. | 49.21M | -1.27% | 31,873 | - |
| 422 | CVM | CEL-SCI Corporation | 48.92M | -1.61% | 54,033 | - |
| 423 | IOBT | IO Biotech, Inc. | 48.67M | -1.70% | 319,094 | - |
| 424 | NRXP | NRx Pharmaceuticals, Inc. | 48.25M | -4.69% | 401,140 | 242.00K |
| 425 | TELO | Telomir Pharmaceuticals, Inc. | 47.79M | -2.80% | 334,446 | - |
| 426 | SNTI | Senti Biosciences, Inc. | 47.59M | 2.84% | 74,771 | - |
| 427 | IBO | Impact BioMedical Inc. | 47.08M | 2.48% | 55,513 | 25.00K |
| 428 | LVTX | LAVA Therapeutics N.V. | 45.77M | -3.87% | 285,521 | 4.99M |
| 429 | CELU | Celularity Inc. | 45.64M | 1.18% | 67,004 | 40.58M |
| 430 | CALC | CalciMedica, Inc. | 45.53M | 0.13% | 14,113 | - |
| 431 | KZR | Kezar Life Sciences, Inc. | 45.11M | -0.65% | 24,055 | - |
| 432 | GRCE | Grace Therapeutics, Inc. | 44.36M | 0.64% | 131,251 | - |
| 433 | EVAX | Evaxion A/S | 44.34M | 9.43% | 177,149 | 7.65M |
| 434 | JUNS | Jupiter Neurosciences, Inc. | 42.84M | -5.38% | 74,795 | - |
| 435 | IPSC | Century Therapeutics, Inc. | 42.84M | -5.07% | 632,463 | 113.34M |
| 436 | CUE | Cue Biopharma, Inc. | 42.58M | -6.79% | 272,246 | 7.10M |
| 437 | ICCC | ImmuCell Corporation | 41.61M | -2.95% | 12,205 | 27.77M |
| 438 | HOWL | Werewolf Therapeutics, Inc. | 41.49M | -7.57% | 465,207 | 1.14M |
| 439 | PDSB | PDS Biotechnology Corporation | 41.37M | 0.81% | 645,642 | - |
| 440 | GNTA | Genenta Science S.p.A. | 40.77M | -1.69% | 147,186 | - |
| 441 | APLT | Applied Therapeutics, Inc. | 40.51M | -1.51% | 8,680,829 | 1.00M |
| 442 | ATNM | Actinium Pharmaceuticals, Inc. | 40.24M | -5.15% | 167,647 | 90.00K |
| 443 | SER | Serina Therapeutics, Inc. | 40.10M | -2.69% | 9,233 | 116.00K |
| 444 | SKYE | Skye Bioscience, Inc. | 40.07M | -4.58% | 246,246 | - |
| 445 | INMB | INmune Bio, Inc. | 39.61M | -1.32% | 329,532 | 50.00K |
| 446 | XLO | Xilio Therapeutics, Inc. | 39.38M | -7.06% | 926,333 | 31.80M |
| 447 | BTAI | BioXcel Therapeutics, Inc. | 39.15M | 2.87% | 682,777 | 752.00K |
| 448 | VRCA | Verrica Pharmaceuticals Inc. | 37.97M | -10.27% | 115,548 | 30.83M |
| 449 | RADX | Radiopharm Theranostics Limited | 37.77M | -2.81% | 33,701 | 8.20M |
| 450 | MURA | Mural Oncology plc | 36.30M | 0.72% | 47,213 | - |
| 451 | TVRD | Tvardi Therapeutics, Inc. | 35.84M | -2.80% | 78,383 | - |
| 452 | VERU | Veru Inc. | 35.79M | -6.69% | 272,067 | 16.89M |
| 453 | OKUR | OnKure Therapeutics, Inc. | 35.50M | -5.07% | 50,754 | - |
| 454 | GBIO | Generation Bio Co. | 33.76M | -3.28% | 93,202 | 15.27M |
| 455 | FGEN | FibroGen, Inc. | 33.74M | -2.46% | 23,685 | 8.30M |
| 456 | LTRN | Lantern Pharma Inc. | 33.55M | -8.26% | 67,262 | - |
| 457 | DYAI | Dyadic International, Inc. | 33.48M | -0.34% | 224,625 | 3.34M |
| 458 | LNAI | Lunai Bioworks Inc. | 33.38M | -4.00% | 1,107,768 | - |
| 459 | MAIA | MAIA Biotechnology, Inc. | 32.26M | -5.33% | 174,148 | - |
| 460 | PLUR | Pluri Inc. | 32.22M | 10.80% | 87,671 | 1.33M |
| 461 | RNTX | Rein Therapeutics Inc. | 32.16M | 9.52% | 221,748 | - |
| 462 | APLM | Apollomics, Inc. | 31.66M | -17.51% | 29,860 | 198.00K |
| 463 | NXTC | NextCure, Inc. | 31.21M | -1.60% | 30,366 | - |
| 464 | HYPD | Hyperion DeFi, Inc. | 30.94M | -8.67% | 273,105 | 345.32K |
| 465 | NERV | Minerva Neurosciences, Inc. | 30.35M | 0.93% | 72,620 | - |
| 466 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 30.11M | -2.22% | 613,501 | 1.00M |
| 467 | ANTX | AN2 Therapeutics, Inc. | 29.59M | - | 29,581 | - |
| 468 | KLTO | Klotho Neurosciences, Inc. | 29.16M | -11.51% | 887,239 | - |
| 469 | IGC | IGC Pharma, Inc. | 28.72M | -4.20% | 504,066 | 1.11M |
| 470 | RNXT | RenovoRx, Inc. | 28.53M | 6.27% | 340,989 | 928.00K |
| 471 | BRNS | Barinthus Biotherapeutics plc | 28.43M | -4.60% | 96,757 | 14.97M |
| 472 | LIMN | Liminatus Pharma, Inc. | 28.42M | -6.25% | 124,561 | - |
| 473 | CLGN | CollPlant Biotechnologies Ltd. | 27.21M | - | 7,402 | 2.40M |
| 474 | NRSN | NeuroSense Therapeutics Ltd. | 26.80M | -1.83% | 439,524 | - |
| 475 | NRXS | NeurAxis, Inc. | 26.74M | -1.18% | 90,722 | 3.36M |
| 476 | XCUR | Exicure, Inc. | 26.64M | -11.81% | 43,930 | 500.00K |
| 477 | RLYB | Rallybio Corporation | 25.77M | -2.27% | 393,951 | 674.00K |
| 478 | BOLD | Boundless Bio, Inc. | 24.85M | -3.48% | 41,549 | - |
| 479 | LIXT | Lixte Biotechnology Holdings, Inc. | 24.76M | 1.62% | 23,433 | - |
| 480 | CASI | CASI Pharmaceuticals, Inc. | 24.66M | - | 14,219 | 26.85M |
| 481 | LEXX | Lexaria Bioscience Corp. | 24.58M | 0.45% | 294,735 | 615.92K |
| 482 | NNVC | NanoViricides, Inc. | 24.06M | -12.06% | 450,322 | - |
| 483 | QNTM | Quantum BioPharma Ltd. | 23.91M | -1.90% | 79,596 | - |
| 484 | QTTB | Q32 Bio Inc. | 23.75M | -8.96% | 108,866 | - |
| 485 | PASG | Passage Bio, Inc. | 23.65M | -5.58% | 31,153 | - |
| 486 | CVKD | Cadrenal Therapeutics, Inc. | 23.62M | 1.06% | 10,702 | - |
| 487 | DARE | Daré Bioscience, Inc. | 23.29M | -4.68% | 153,119 | -57.13K |
| 488 | GLTO | Galecto, Inc. | 23.03M | -14.66% | 201,733 | - |
| 489 | INTS | Intensity Therapeutics, Inc. | 22.82M | -11.09% | 2,707,732 | - |
| 490 | NEUP | Neuphoria Therapeutics Inc. | 22.64M | -4.75% | 64,397 | 15.65M |
| 491 | PTN | Palatin Technologies, Inc. | 22.39M | 5.00% | 35,815 | 8.85M |
| 492 | IBIO | iBio, Inc. | 22.38M | -8.71% | 1,014,454 | 500.00K |
| 493 | ENLV | Enlivex Therapeutics Ltd. | 22.17M | -2.78% | 135,106 | - |
| 494 | MBRX | Moleculin Biotech, Inc. | 21.46M | -3.81% | 1,051,831 | - |
| 495 | GDTC | CytoMed Therapeutics Limited | 20.77M | -0.55% | 30,171 | 573.19K |
| 496 | PMN | ProMIS Neurosciences, Inc. | 20.55M | -8.07% | 476,458 | - |
| 497 | CING | Cingulate Inc. | 19.40M | 1.17% | 59,060 | - |
| 498 | SYBX | Synlogic, Inc. | 18.72M | -1.23% | 43,258 | 8.00K |
| 499 | CTXR | Citius Pharmaceuticals, Inc. | 18.29M | -1.00% | 270,931 | - |
| 500 | APVO | Aptevo Therapeutics Inc. | 18.20M | -11.48% | 979,621 | - |
| 501 | ATHA | Athira Pharma, Inc. | 17.91M | -4.62% | 33,146 | - |
| 502 | ITRM | Iterum Therapeutics plc | 17.78M | -3.90% | 1,711,490 | 390.00K |
| 503 | LSTA | Lisata Therapeutics, Inc. | 17.55M | -1.97% | 18,658 | 1.07M |
| 504 | LPCN | Lipocine Inc. | 17.49M | -1.87% | 15,412 | 4.32M |
| 505 | TRAW | Traws Pharma, Inc. | 17.10M | 1.42% | 378,648 | 2.85M |
| 506 | PULM | Pulmatrix, Inc. | 17.04M | 6.51% | 6,999 | 3.00K |
| 507 | ABP | Abpro Holdings, Inc. | 16.99M | 3.58% | 45,961 | 183.00K |
| 508 | FBLG | FibroBiologics, Inc. | 16.70M | -5.78% | 941,433 | - |
| 509 | MRKR | Marker Therapeutics, Inc. | 16.58M | -8.79% | 581,773 | 4.69M |
| 510 | AKTX | Akari Therapeutics, Plc | 16.52M | -7.30% | 85,832 | - |
| 511 | TPST | Tempest Therapeutics, Inc. | 16.34M | -22.53% | 512,729 | - |
| 512 | MTVA | MetaVia Inc. | 16.05M | -13.22% | 293,318 | - |
| 513 | HOTH | Hoth Therapeutics, Inc. | 15.98M | -10.43% | 1,944,444 | - |
| 514 | CANF | Can-Fite BioPharma Ltd. | 15.72M | -6.95% | 4,990,419 | 560.00K |
| 515 | QNRX | Quoin Pharmaceuticals, Ltd. | 15.45M | 1.32% | 96,116 | - |
| 516 | PCSA | Processa Pharmaceuticals, Inc. | 15.44M | -2.19% | 1,800,050 | - |
| 517 | NCNA | NuCana plc | 14.80M | 6.12% | 151,320 | - |
| 518 | ALLR | Allarity Therapeutics, Inc. | 14.42M | -7.22% | 313,406 | - |
| 519 | NCEL | NewcelX Ltd. | 14.36M | -4.83% | 29,152 | - |
| 520 | BLRX | BioLineRx Ltd. | 14.33M | 1.50% | 24,631 | 17.25M |
| 521 | KAPA | Kairos Pharma, Ltd. | 14.24M | -3.82% | 218,380 | - |
| 522 | CRIS | Curis, Inc. | 13.96M | -4.42% | 137,966 | 11.65M |
| 523 | KZIA | Kazia Therapeutics Limited | 13.72M | -3.36% | 668,527 | 1.20M |
| 524 | CLSD | Clearside Biomedical, Inc. | 13.66M | -9.34% | 44,674 | 3.33M |
| 525 | DWTX | Dogwood Therapeutics, Inc. | 13.64M | -0.34% | 28,016 | - |
| 526 | BCDA | BioCardia, Inc. | 13.58M | -3.03% | 102,447 | 3.00K |
| 527 | BCTX | BriaCell Therapeutics Corp. | 13.55M | -0.57% | 27,299 | - |
| 528 | LGVN | Longeveron Inc. | 12.87M | -1.82% | 311,977 | 1.44M |
| 529 | PHIO | Phio Pharmaceuticals Corp. | 12.81M | -4.80% | 463,041 | - |
| 530 | SNGX | Soligenix, Inc. | 12.81M | -3.79% | 290,660 | 2.34K |
| 531 | CMMB | Chemomab Therapeutics Ltd. | 12.57M | -10.00% | 188,403 | - |
| 532 | EDSA | Edesa Biotech, Inc. | 12.18M | - | 22,242 | - |
| 533 | COCP | Cocrystal Pharma, Inc. | 12.00M | -7.08% | 131,537 | - |
| 534 | CLRB | Cellectar Biosciences, Inc. | 11.96M | -1.40% | 38,308 | - |
| 535 | GOVX | GeoVax Labs, Inc. | 11.91M | -3.30% | 930,594 | 3.35M |
| 536 | OSRH | OSR Holdings, Inc. | 11.71M | -7.24% | 136,897 | -90.52K |
| 537 | APM | Aptorum Group Limited | 11.65M | -11.73% | 244,654 | - |
| 538 | VYNE | VYNE Therapeutics Inc. | 11.60M | -3.30% | 1,214,597 | 524.00K |
| 539 | IMRN | Immuron Limited | 11.50M | 5.88% | 97,717 | 4.78M |
| 540 | IMNN | Imunon, Inc. | 11.33M | -2.38% | 29,202 | - |
| 541 | ICU | SeaStar Medical Holding Corporation | 11.17M | -0.39% | 833,189 | 881.00K |
| 542 | SNSE | Sensei Biotherapeutics, Inc. | 11.10M | -12.13% | 29,711 | - |
| 543 | PPCB | Propanc Biopharma, Inc. | 10.60M | -3.74% | 46,204 | - |
| 544 | ADXN | Addex Therapeutics Ltd | 10.45M | -11.83% | 21,579 | 210.35K |
| 545 | EVGN | Evogene Ltd. | 10.41M | -7.69% | 94,883 | 8.02M |
| 546 | CLDI | Calidi Biotherapeutics, Inc. | 10.10M | -4.17% | 131,923 | - |
| 547 | CELZ | Creative Medical Technology Holdings, Inc. | 10.09M | -6.19% | 194,712 | 6.00K |
| 548 | ERNA | Ernexa Therapeutics Inc. | 10.05M | -7.91% | 52,608 | 1,000.00 |
| 549 | BRTX | BioRestorative Therapies, Inc. | 9.85M | -22.38% | 397,520 | 383.40K |
| 550 | BIVI | BioVie Inc. | 9.57M | -7.30% | 90,185 | - |
| 551 | AEON | AEON Biopharma, Inc. | 9.55M | -12.79% | 416,956 | - |
| 552 | BOLT | Bolt Biotherapeutics, Inc. | 9.21M | 2.56% | 24,377 | 5.20M |
| 553 | MBIO | Mustang Bio, Inc. | 8.39M | -4.17% | 51,670 | - |
| 554 | XTLB | XTL Biopharmaceuticals Ltd. | 8.33M | -5.66% | 25,501 | 451.00K |
| 555 | ACXP | Acurx Pharmaceuticals, Inc. | 8.15M | -2.25% | 41,106 | - |
| 556 | TCRT | Alaunos Therapeutics, Inc. | 7.92M | 7.25% | 138,272 | 6.00K |
| 557 | GTBP | GT Biopharma, Inc. | 7.50M | 3.68% | 953,961 | - |
| 558 | ALZN | Alzamend Neuro, Inc. | 7.49M | -14.72% | 173,669 | - |
| 559 | INAB | IN8bio, Inc. | 7.37M | -1.85% | 77,235 | - |
| 560 | PHGE | BiomX Inc. | 7.30M | 2.61% | 759,925 | - |
| 561 | TOVX | Theriva Biologics, Inc. | 7.23M | -6.95% | 4,018,731 | - |
| 562 | ADIL | Adial Pharmaceuticals, Inc. | 7.16M | -5.72% | 249,365 | - |
| 563 | RNAZ | TransCode Therapeutics, Inc. | 7.14M | -4.78% | 7,524 | - |
| 564 | APRE | Aprea Therapeutics, Inc. | 7.00M | -7.50% | 85,805 | 488.24K |
| 565 | PLRZ | Polyrizon Ltd. | 6.93M | -16.63% | 403,432 | - |
| 566 | PPBT | Purple Biotech Ltd | 6.61M | -0.21% | 223,851 | - |
| 567 | KPRX | Kiora Pharmaceuticals, Inc. | 6.60M | -6.25% | 37,121 | 20.00K |
| 568 | ENSC | Ensysce Biosciences, Inc. | 5.70M | -12.02% | 344,267 | 4.49M |
| 569 | VIVS | VivoSim Labs, Inc. | 5.66M | 1.40% | 35,012 | 140.00K |
| 570 | LYRA | Lyra Therapeutics, Inc. | 5.56M | -9.80% | 39,593 | 600.00K |
| 571 | CYCN | Cyclerion Therapeutics, Inc. | 5.40M | 0.71% | 89,476 | 2.86M |
| 572 | MTNB | Matinas BioPharma Holdings, Inc. | 5.38M | 3.95% | 15,371 | - |
| 573 | XBIO | Xenetic Biosciences, Inc. | 5.29M | -9.06% | 101,513 | 2.86M |
| 574 | GNPX | Genprex, Inc. | 5.14M | -5.39% | 151,944 | - |
| 575 | GRI | GRI Bio, Inc. | 5.13M | 20.71% | 695,312 | - |
| 576 | REVB | Revelation Biosciences, Inc. | 5.04M | -0.45% | 225,097 | - |
| 577 | SILO | Silo Pharma, Inc. | 4.84M | -7.95% | 187,995 | 72.10K |
| 578 | ASBP | Aspire Biopharma Holdings, Inc. | 4.84M | -1.51% | 22,625,448 | 1.94K |
| 579 | JAGX | Jaguar Health, Inc. | 4.63M | -8.15% | 115,235 | 11.79M |
| 580 | KALA | KALA BIO, Inc. | 4.56M | 2.50% | 122,519 | - |
| 581 | CDIO | Cardio Diagnostics Holdings, Inc. | 4.53M | -3.13% | 40,883 | 15.78K |
| 582 | GLMD | Galmed Pharmaceuticals Ltd. | 4.47M | -13.51% | 982,723 | - |
| 583 | AIXC | AIxCrypto Holdings, Inc. | 4.46M | -8.68% | 203,264 | - |
| 584 | PMCB | PharmaCyte Biotech, Inc. | 4.42M | -8.96% | 22,893 | - |
| 585 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 4.15M | -3.81% | 38,240 | 1.36M |
| 586 | HCWB | HCW Biologics Inc. | 4.14M | -3.85% | 78,131 | 422.03K |
| 587 | ENTO | Entero Therapeutics, Inc. | 3.96M | -19.16% | 133,743 | - |
| 588 | PTIX | Protagenic Therapeutics, Inc. | 3.87M | - | 48,509 | - |
| 589 | SPRC | SciSparc Ltd. | 3.81M | -4.47% | 11,656 | 927.00K |
| 590 | OGEN | Oragenics, Inc. | 3.81M | -8.53% | 169,221 | - |
| 591 | CNSP | CNS Pharmaceuticals, Inc. | 3.74M | -3.27% | 5,484 | - |
| 592 | ONCO | Onconetix, Inc. | 3.64M | -2.55% | 10,911 | 1.22M |
| 593 | BGMS | Bio Green Med Solution, Inc. | 3.61M | -4.65% | 45,130 | 81.00K |
| 594 | ELAB | PMGC Holdings Inc. | 3.51M | -5.23% | 62,856 | -241.53K |
| 595 | ARTL | Artelo Biosciences, Inc. | 3.45M | -7.57% | 55,225 | - |
| 596 | AZTR | Azitra, Inc. | 3.26M | -3.22% | 453,778 | 7.50K |
| 597 | PBM | Psyence Biomedical Ltd. | 3.22M | -38.35% | 20,365,229 | - |
| 598 | SLRX | Salarius Pharmaceuticals, Inc. | 3.17M | -4.61% | 723,224 | - |
| 599 | XRTX | XORTX Therapeutics Inc. | 3.13M | -3.19% | 46,873 | - |
| 600 | KTTA | Pasithea Therapeutics Corp. | 3.09M | -12.78% | 4,036,450 | - |
| 601 | ENVB | Enveric Biosciences, Inc. | 3.03M | 0.17% | 52,814 | - |
| 602 | SCNI | Scinai Immunotherapeutics Ltd. | 2.90M | -7.91% | 15,510 | 1.15M |
| 603 | CDT | CDT Equity Inc. | 2.70M | -4.60% | 42,394 | - |
| 604 | BDRX | Biodexa Pharmaceuticals Plc | 2.43M | 1.81% | 41,265 | 104.90K |
| 605 | INDP | Indaptus Therapeutics, Inc. | 1.94M | -15.46% | 99,520 | - |
| 606 | MLEC | Moolec Science SA | 1.89M | -16.38% | 195,592 | 7.83M |
| 607 | VRAX | Virax Biolabs Group Limited | 1.74M | -8.74% | 94,941 | 6.33K |
| 608 | DRMA | Dermata Therapeutics, Inc. | 1.70M | 2.46% | 101,368 | - |
| 609 | SLXN | Silexion Therapeutics Corp | 1.32M | -4.86% | 32,154 | - |
| 610 | CMND | Clearmind Medicine Inc. | 1.09M | -1.83% | 7,442,268 | - |
| 611 | ADTX | Aditxt, Inc. | 126.40K | -17.53% | 152,822 | 5.95K |